Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) released a profit for first quarter that Dropped, from the same period last year
The company's bottom line totaled RMB31.896 million, or RMB0.03 per share. This compares with RMB50.711 million, or RMB0.05 per share, last year.
The company's revenue for the period rose 2.8% to RMB900.439 million from RMB876.077 million last year.
Lushang Freda Pharmaceutical Co.,Ltd. earnings at a glance (GAAP) :
-Earnings: RMB31.896 Mln. vs. RMB50.711 Mln. last year.-EPS: RMB0.03 vs. RMB0.05 last year.-Revenue: RMB900.439 Mln vs. RMB876.077 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.